|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-1-19
|
|
pubmed:abstractText |
The aim of this study was to evaluate the absolute bioavailability and the metabolism of omeprazole following single intravenous and oral administrations to healthy subjects in relation to CYP2C19 genotypes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0031-6970
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
63
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
143-9
|
|
pubmed:meshHeading |
pubmed-meshheading:17203292-Administration, Oral,
pubmed-meshheading:17203292-Adult,
pubmed-meshheading:17203292-Anti-Ulcer Agents,
pubmed-meshheading:17203292-Area Under Curve,
pubmed-meshheading:17203292-Aryl Hydrocarbon Hydroxylases,
pubmed-meshheading:17203292-Biological Availability,
pubmed-meshheading:17203292-Cross-Over Studies,
pubmed-meshheading:17203292-Dose-Response Relationship, Drug,
pubmed-meshheading:17203292-Female,
pubmed-meshheading:17203292-Heterozygote,
pubmed-meshheading:17203292-Homozygote,
pubmed-meshheading:17203292-Humans,
pubmed-meshheading:17203292-Hydroxylation,
pubmed-meshheading:17203292-Injections, Intravenous,
pubmed-meshheading:17203292-Male,
pubmed-meshheading:17203292-Mixed Function Oxygenases,
pubmed-meshheading:17203292-Omeprazole,
pubmed-meshheading:17203292-Oxidation-Reduction
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations.
|
|
pubmed:affiliation |
Department of Clinical Pharmacology, Hirosaki University School of Medicine, Hirosaki, Japan. uno-hki@umin.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
